Articles related to SCHIZOPHRENIA

This meta-analysis highlights a significant association between cat ownership and an increased risk of schizophrenia-related disorders, emphasizing the need for further exploration of environmental factors in mental health.

Explore groundbreaking therapies in the pipeline: Onivyde for pancreatic cancer, showing marked survival benefits, and roluperidone, offering new hope in managing schizophrenia’s negative symptoms.

Explore the latest advances in schizophrenia research and understand how TAAR1 agonism could potentially change the treatment paradigm. Join us in this educational journey.

Ulotaront’s failure to meet its primary endpoint in recent phase 3 trials raises questions about the drug’s future and emphasizes the need for more effective treatments in the field of schizophrenia.

New research identifies the placenta as a significant factor in schizophrenia risk, revealing more than 100 genes that impact the disorder and suggesting new avenues for prevention and treatment.

This case study highlights the critical role of vitamin B12 testing in diagnosing and treating neuropsychiatric disorders, urging physicians to consider this simple yet often overlooked test.